MANCINA, ROSELLINA MARGHERITA
 Distribuzione geografica
Continente #
AS - Asia 1.001
SA - Sud America 366
NA - Nord America 210
EU - Europa 140
AF - Africa 18
Continente sconosciuto - Info sul continente non disponibili 2
AN - Antartide 1
Totale 1.738
Nazione #
SG - Singapore 326
BR - Brasile 287
HK - Hong Kong 197
US - Stati Uniti d'America 185
VN - Vietnam 142
KR - Corea 139
CN - Cina 130
AR - Argentina 38
GB - Regno Unito 21
FR - Francia 20
ID - Indonesia 20
DE - Germania 15
EC - Ecuador 14
IT - Italia 11
BD - Bangladesh 9
CA - Canada 9
CO - Colombia 9
MX - Messico 9
PY - Paraguay 9
ZA - Sudafrica 9
LT - Lituania 8
UA - Ucraina 8
RU - Federazione Russa 7
SE - Svezia 7
PL - Polonia 6
EG - Egitto 5
ES - Italia 5
IN - India 5
JP - Giappone 5
NL - Olanda 5
PE - Perù 5
UZ - Uzbekistan 5
BE - Belgio 4
CH - Svizzera 4
TR - Turchia 4
EE - Estonia 3
KG - Kirghizistan 3
PT - Portogallo 3
SA - Arabia Saudita 3
UY - Uruguay 3
AL - Albania 2
DK - Danimarca 2
GR - Grecia 2
IE - Irlanda 2
JM - Giamaica 2
KZ - Kazakistan 2
MA - Marocco 2
PK - Pakistan 2
SK - Slovacchia (Repubblica Slovacca) 2
SV - El Salvador 2
AE - Emirati Arabi Uniti 1
AO - Angola 1
AQ - Antartide 1
BH - Bahrain 1
BY - Bielorussia 1
CW - ???statistics.table.value.countryCode.CW??? 1
CY - Cipro 1
DO - Repubblica Dominicana 1
GH - Ghana 1
GT - Guatemala 1
HN - Honduras 1
IL - Israele 1
IQ - Iraq 1
LB - Libano 1
LK - Sri Lanka 1
LU - Lussemburgo 1
NP - Nepal 1
RS - Serbia 1
SY - Repubblica araba siriana 1
VE - Venezuela 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 1.738
Città #
Hong Kong 197
Seoul 139
Singapore 108
Ho Chi Minh City 56
Beijing 28
Hanoi 27
São Paulo 27
Ashburn 23
Los Angeles 14
Rio de Janeiro 13
Frankfurt am Main 12
Dallas 10
Haiphong 9
Guayaquil 8
London 8
New York 7
Dhaka 6
Belo Horizonte 5
Da Nang 5
Gothenburg 5
Hillsboro 5
Lima 5
Santo André 5
Tashkent 5
Thái Bình 5
Tokyo 5
Warsaw 5
Belém 4
Boston 4
Brasília 4
Brussels 4
Curitiba 4
Hải Dương 4
Johannesburg 4
Juiz de Fora 4
Montreal 4
Phoenix 4
Santa Clara 4
São José dos Campos 4
Zurich 4
Araçatuba 3
Betim 3
Bexley 3
Bishkek 3
Biên Hòa 3
Bogotá 3
Cairo 3
Can Tho 3
Caxias do Sul 3
Medellín 3
Montevideo 3
Ninh Bình 3
Ottawa 3
Quilmes 3
Quito 3
Ribeirão Preto 3
Rondonópolis 3
St Petersburg 3
São José 3
São José do Rio Preto 3
Tallinn 3
Uberlândia 3
Amsterdam 2
Ankara 2
Araguaína 2
Athens 2
Açailândia 2
Bento Gonçalves 2
Bratislava 2
Brooklyn 2
Buenos Aires 2
Camaçari 2
Canaã dos Carajás 2
Cape Town 2
Chennai 2
Ciudad del Este 2
Concepción 2
Council Bluffs 2
Cremona 2
Criciúma 2
Córdoba 2
Dublin 2
Florence 2
Florianópolis 2
Gardner 2
Goiânia 2
Guarulhos 2
Ha Long 2
Iguatu 2
Jakarta 2
Jember 2
Kyiv 2
Macapá 2
Niterói 2
Porto Alegre 2
Porto Seguro 2
Porto Velho 2
Potenza 2
Quảng Ngãi 2
Quảng Ninh 2
Totale 936
Nome #
Exome-Wide Association Study on Alanine Aminotransferase Identifies Sequence Variants in the GPAM and APOE Associated With Fatty Liver Disease 40
Cross talk between liver and adipose tissue: A new role for PNPLA3? 38
Cellular Genome-Scale Metabolic Modeling Identifies New Potential Drug Targets Against Hepatocellular Carcinoma 38
Molecular analysis of three known and one novel LPL variants in patients with type I hyperlipoproteinemia 38
Adverse effects of fructose on cardiometabolic risk factors and hepatic lipid metabolism in subjects with abdominal obesity 38
An Integrated Understanding of the Rapid Metabolic Benefits of a Carbohydrate-Restricted Diet on Hepatic Steatosis in Humans 36
Recombinant PNPLA3 protein shows triglyceride hydrolase activity and its I148M mutation results in loss of function 36
Downregulation of the MARC1 p.A165 risk allele reduces hepatocyte lipid content by increasing beta-oxidation. 36
The rs2294918 E434K variant modulates patatin‐like phospholipase domain‐containing 3 expression and liver damage 35
Partitioned polygenic risk scores identify distinct types of metabolic dysfunction-associated steatotic liver disease 35
PSD3 downregulation confers protection against fatty liver disease 35
Genetic Susceptibility to Chronic Liver Disease in Individuals from Pakistan 34
Phytomedicines to Target Hepatitis B Virus DNA Replication: Current Limitations and Future Approaches 34
PNPLA3 I148M polymorphism and progressive liver disease 33
Deregulation of SGK1 in Ulcerative Colitis: A Paradoxical Relationship Between Immune Cells and Colonic Epithelial Cells 33
ANGPTL3 Downregulation Increases Intracellular Lipids by Reducing Energy Utilization 33
ANGPTL4 gene E40K variation protects against obesity‐associated dyslipidemia in participants with obesity 33
Accuracy of controlled attenuation parameter for assessing liver steatosis in individuals with morbid obesity before bariatric surgery 32
Causal relationship of hepatic fat with liver damage and insulin resistance in nonalcoholic fatty liver 32
DEPDC5 variants increase fibrosis progression in Europeans with chronic hepatitis C virus infection 30
The COBLL1 C allele is associated with lower serum insulin levels and lower insulin resistance in overweight and obese children 30
Individuals with familial hypercholesterolemia and cardiovascular events have higher circulating Lp(a) levels 29
PNPLA3 I148M Variant Influences Circulating Retinol in Adults with Nonalcoholic Fatty Liver Disease or Obesity 29
Genetic variants in the MTHFR are not associated with fatty liver disease 29
TM6SF2 and PNPLA3: a potential dynamic duo? 29
Effects of listening to music in digestive endoscopy: A prospective intervention study led by nursing 28
The MBOAT7-TMC4 Variant rs641738 Increases Risk of Nonalcoholic Fatty Liver Disease in Individuals of European Descent 28
MBOAT7 rs641738 variant and hepatocellular carcinoma in non-cirrhotic individuals 28
Virtual genetic diagnosis for familial hypercholesterolemia powered by machine learning 27
PNPLA3 I148M (rs738409) genetic variant is associated with hepatocellular carcinoma in obese individuals 27
Generation and validation of a classification model to diagnose familial hypercholesterolaemia in adults 27
The IRS1 rs2943641 Variant and Risk of Future Cancer Among Morbidly Obese Individuals 26
A two gene-based risk score predicts alcoholic cirrhosis development in males with at-risk alcohol consumption 26
Genetic diagnosis of familial hypercholesterolaemia by targeted next‐generation sequencing 26
Pnpla3 silencing with antisense oligonucleotides ameliorates nonalcoholic steatohepatitis and fibrosis in Pnpla3 I148M knock-in mice 25
Protein phosphatase 1 regulatory subunit 3B gene variation protects against hepatic fat accumulation and fibrosis in individuals at high risk of nonalcoholic fatty liver disease 25
Development and Validation of a Score for Fibrotic Nonalcoholic Steatohepatitis 25
Beta-glucan, inositol and digestive enzymes improve quality of life of patients with inflammatory bowel disease and irritable bowel syndrome 25
PNPLA3 overexpression results in reduction of proteins predisposing to fibrosis 25
New Diagnostic and Prognostic Models for the Development of Alcoholic Cirrhosis Based on Genetic Predisposition and Alcohol History 25
Transmembrane 6 superfamily member 2 gene E167K variant impacts on steatosis and liver damage in chronic hepatitis C patients 25
Mitochondrial amidoxime-reducing component 1 p.Ala165Thr increases protein degradation mediated by the proteasome 24
PNPLA3 148M Carriers with Inflammatory Bowel Diseases Have Higher Susceptibility to Hepatic Steatosis and Higher Liver Enzymes 24
Gastrointestinal Symptoms of and Psychosocial Changes in Inflammatory Bowel Disease: A Nursing-Led Cross-Sectional Study of Patients in Clinical Remission 24
Effects of PNPLA3 I148M on hepatic lipid and very-low-density lipoprotein metabolism in humans 24
IL32 downregulation lowers triglycerides and type I collagen in di-lineage human primary liver organoids 24
The TM6SF2 E167K genetic variant induces lipid biosynthesis and reduces apolipoprotein B secretion in human hepatic 3D spheroids 24
Transmembrane-6 superfamily member 2 (TM6SF2) E167K variant increases susceptibility to hepatic steatosis in obese children 24
PNPLA3 has retinyl-palmitate lipase activity in human hepatic stellate cells 23
Liver transcriptomics highlights interleukin-32 as novel NAFLD-related cytokine and candidate biomarker 23
MBOAT7 is anchored to endomembranes by six transmembrane domains 23
Effects of TM6SF2 E167K on hepatic lipid and very low-density lipoprotein metabolism in humans 23
Paradoxical dissociation between hepatic fat content and de novo lipogenesis due to PNPLA3 sequence variant 23
Patatin-like phospholipase domain-containing 3 (PNPLA3) I148M (rs738409) affects hepatic VLDL secretion in humans and in vitro 23
Rare ATG7 genetic variants predispose patients to severe fatty liver disease 22
Ulcerative Colitis as an Independent Risk Factor for Hepatic Steatosis 22
PCSK9 rs11591147 R46L Loss-of-Function Variant Protects Against Liver Damage in Individuals with NAFLD 20
Identification and characterization of two novel mutations in the LPL gene causing type I hyperlipoproteinemia 20
The rs2294918 E434K variant modulates PNPLA3 expression and liver damage 19
Macrophage scavenger receptor 1 mediates lipid-induced inflammation in non-alcoholic fatty liver disease 18
LPIAT1/MBOAT7 depletion increases triglyceride synthesis fueled by high phosphatidylinositol turnover 18
High prevalence of genetic determined familial hypercholesterolemia in premature coronary artery disease 18
Genome-wide interaction study with BMI identifies CYP7A1 and GIPR as genetic modulators of MASLD 18
PCSK9 rs11591147 R46L loss-of-function variant protects against liver damage in individuals with non-alcoholic fatty liver 18
Validation of Interleukin-32 as a new circulating fatty liver biomarker 17
Statin use and non-alcoholic steatohepatitis in at risk individuals 17
Telomerase reverse transcriptase germline mutations and hepatocellular carcinoma in patients with nonalcoholic fatty liver disease 16
Natural Extracts as Modifiers of Intracellular Lipid Handling 16
Satisfaction in Social Roles and Physical Function in Immune-mediated Inflammatory Diseases: A Cross-Sectional Study 15
PCSK7 gene variation bridges atherogenic dyslipidemia with hepatic inflammation in NAFLD patients 14
Totale 1.857
Categoria #
all - tutte 20.964
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.964


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202467 0 0 0 0 0 0 0 0 30 36 0 1
2024/2025720 19 55 2 9 98 147 76 25 66 38 154 31
2025/20261.070 118 115 299 367 160 11 0 0 0 0 0 0
Totale 1.857